Skip to main content

Table 5 Comparison of characteristics of patients infected by WT and different frequency mutant M. pneumoniae determined by ASPCR assays

From: Allele-specific real-time PCR testing for minor macrolide-resistant Mycoplasma Pneumoniae

Characteristic WT Mutant M. pneumoniae (Low frequency/High frequency) P Two groups/Three groups
n 15 139 (52/87)  
Mean age (year) 5.58 ± 3.35 6.43 ± 3.14 (6.38 ± 2.91/6.46 ± 3.29) 0.408/0.646 (F = 0.438)
Female (no, %) 7 (46.7%) 64 (46.0%) (26 (40.6%)/38 (59.4%)) 0.963/0.769 (χ2 = 0.526)
Disease process (days) 6.86 ± 7.58 8.26 ± 6.49 (9.42 ± 8.79/7.71 ± 5.05) 0.698/0.336 (F = 1.099)
  1. WT: no macrolide resistance mutation detected (group A); mutant M. pneumoniae: A2063G or A2064G mutation detected (group B); low frequency: macrolide resistance mutation present at low percentage (S and < 50%) (group C); high frequency: macrolide resistance mutation present at high percentage (50%) (group D); two groups: WT (group A) and mutant M. pneumoniae (group B); three groups: WT (group A), low frequency (group C) and high frequency (group D)